“The neurophysiological brain-fingerprint of Parkinson’s disease.” Jason da Silva Castanheira, et al. – McGill University. Background: Cortical neural activity...
Month: January 2024
“Plasma biomarkers of neurodegeneration in patients with Parkinson’s disease and dementia with Lewy bodies and at-risk individuals of Lewy...
“Genetic Associations of Lipid-Lowering Drugs and Parkinson’s Disease: A Mendelian Randomization Study.” Lin Shen, et al. – Xi’an Jiaotong...
“Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease.” Theresa Schmaderer, et al. – UCL...
“A Worldwide Study of White Matter Microstructural Alterations in People Living with Parkinson’s Disease.” Conor Owens-Walton, et al. –...
“A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase.” Emil Gustavsson, et al. –...
“In vivo validation of late-onset Alzheimer’s disease genetic risk factors.” Michael Sasner, et al. – The Jackson Laboratory. Background:...
“Identification of Rare Damaging Missense and Loss of Function Variants in GWAS Loci Using Genome Sequencing Data from Two...
“Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease.” David Berron, et al. –...
“Psychotic symptoms are associated with elevated tau PET signal in the amygdala independent of Alzheimer’s disease clinical severity and...